Search research articles
Contact Us
Filters
Showing results (821-830 of 1,030) with videos related to
Page
of 103
Sort By:
Journal of Proteome Research
|
September 7, 2017
Lessons from the Hamster: Cricetulus griseus Tissue and CHO Cell Line Proteome Comparison
Kelley M Heffner, Deniz Baycin Hizal, George S Yerganian, et al.
Surgery
|
June 8, 2015
Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma
Justin W Ady, Clark Johnsen, Kelly Mojica, et al.
Journal of Medicinal Chemistry
|
August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships
S A Glase, H C Akunne, T G Heffner, et al.
Biotechnology Advances
|
August 7, 2013
CHO microRNA engineering is growing up: recent successes and future challenges
Vaibhav Jadhav, Matthias Hackl, Aliaksandr Druz, et al.
Carcinogenesis
|
October 1, 1995
Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate
G D Stoner, J C Siglin, M A Morse, et al.
Hearing Research
|
July 21, 2016
Volumes of cochlear nucleus regions in rodents
Donald A Godfrey, Augustine C Lee, Walter D Hamilton, et al.
Journal of Medicinal Chemistry
|
December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent
J L Wright, D M Downing, M R Feng, et al.
Disease Models & Mechanisms
|
March 14, 2022
Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants
Stanley M Kanai, Caleb Heffner, Timothy C Cox, et al.
JMIR Formative Research
|
March 6, 2026
Exploring Feature Priorities and User Needs in Developing Virtual Study Assistants
Chi-Shan Tsai, HyunHae Lee, Warren Szewczyk, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 17, 2017
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib
Vamsi K Kota, Jee Hyun Kong, Martha Arellano, et al.
Page
of 103
Search research articles
Search
Showing results (821-830 of 1,030) with videos related to
Sort By:
Page
of 103
Journal of Proteome Research
|
September 7, 2017
Lessons from the Hamster: Cricetulus griseus Tissue and CHO Cell Line Proteome Comparison
Kelley M Heffner, Deniz Baycin Hizal, George S Yerganian, et al.
Surgery
|
June 8, 2015
Oncolytic gene therapy with recombinant vaccinia strain GLV-2b372 efficiently kills hepatocellular carcinoma
Justin W Ady, Clark Johnsen, Kelly Mojica, et al.
Journal of Medicinal Chemistry
|
August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationships
S A Glase, H C Akunne, T G Heffner, et al.
Biotechnology Advances
|
August 7, 2013
CHO microRNA engineering is growing up: recent successes and future challenges
Vaibhav Jadhav, Matthias Hackl, Aliaksandr Druz, et al.
Carcinogenesis
|
October 1, 1995
Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate
G D Stoner, J C Siglin, M A Morse, et al.
Hearing Research
|
July 21, 2016
Volumes of cochlear nucleus regions in rodents
Donald A Godfrey, Augustine C Lee, Walter D Hamilton, et al.
Journal of Medicinal Chemistry
|
December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agent
J L Wright, D M Downing, M R Feng, et al.
Disease Models & Mechanisms
|
March 14, 2022
Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants
Stanley M Kanai, Caleb Heffner, Timothy C Cox, et al.
JMIR Formative Research
|
March 6, 2026
Exploring Feature Priorities and User Needs in Developing Virtual Study Assistants
Chi-Shan Tsai, HyunHae Lee, Warren Szewczyk, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 17, 2017
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib
Vamsi K Kota, Jee Hyun Kong, Martha Arellano, et al.
Page
of 103